The PS19-1904 Track B Capacity Building Assistance providers of Washington University in St. Louis, Latino Commission on AIDS, University of Rochester, and San Francisco Department of Public Health will host a four-part virtual series that will address injectable PrEP. Cabotegravir was approved for HIV PrEP in December 2021, but implementation and uptake have been low. The purpose of this series is to build the capacity of the HIV workforce for injectable PrEP implementation through peer-to-peer learning. This series is for agencies at any stage of implementation.

The sessions will address these 4 topics respectively.

1. Injectable PrEP: What the Science and Users Have to Say About It
2. Implementing Injectable PrEP: Lessons from the Field
3. Financing Injectable PrEP: Strategies and Lessons Learned
4. Putting It All Together

Join us for interactive sessions featuring panels, case studies, and more to enhance staff and provider knowledge on injectable PrEP!